PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 260 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,141,069 | -37.2% | 136,655 | 0.0% | 0.92% | -20.5% |
| Q2 2023 | $1,817,512 | +14.9% | 136,655 | 0.0% | 1.16% | +7.9% |
| Q1 2023 | $1,582,465 | +41.6% | 136,655 | 0.0% | 1.08% | +39.9% |
| Q4 2022 | $1,117,838 | +32.9% | 136,655 | -5.7% | 0.77% | +43.4% |
| Q3 2022 | $841,000 | +31.4% | 144,840 | 0.0% | 0.54% | +22.0% |
| Q2 2022 | $640,000 | -51.4% | 144,840 | 0.0% | 0.44% | -29.6% |
| Q1 2022 | $1,318,000 | -62.5% | 144,840 | -15.7% | 0.62% | -39.9% |
| Q4 2021 | $3,514,000 | – | 171,760 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |